Total Migraine Freedom, a Potential Primary Endpoint to Assess Acute Treatment in Migraine: Comparison to the Current FDA Requirement Using the Complete Rizatriptan Study Database - Rodgers - 2010 - Headache: The Journal of Head and Face Pain - Wiley Onli
Links shared publicly online about this topic.
- 804total visits
Total Migraine Freedom, a Potential Primary Endpoint to Assess Acute Treatment in Migraine: Comparison to the Current FDA Requirement Using the Complete Rizatriptan Study Database - Rodgers - 2010 - Headache: The Journal of Head and Face Pain - Wiley Onli
Total Migraine Freedom, a Potential Primary Endpoint to Assess Acute Treatment in Migraine: Comparison to the Current FDA Requirement Using the Complete Rizatriptan Study Database - Rodgers - 2010 - Headache: The Journal of Head and Face Pain - Wiley Online Library
View full resource at onlinelibrary.wiley.com
Tags: Migraine, Migraine Medication, Triptans, Headache, Vascular Headache, FDA, Maxalt
Most Recently Shared on October 13, 2010 at 3:42 pm By:
Total Migraine Freedom, a Potential Primary Endpoint to Assess Acute Treatment in Migraine: Comparison to the Curr... http://bit.ly/b9pXum
Advertisement
